ArticlemedRxiv : the preprint server for health sciences2026
A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.
James J Kobie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.